Arlington Financial Advisors, LLC Editas Medicine, Inc. Transaction History

Arlington Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$39.27 - $72.94 $172,788 - $320,936	-4,400 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$31.29 - $56.64 $137,676 - $249,216	4,400 New	4,400 $249,000
Q1 2021 Apr 23, 2021	SELL	$39.71 - $90.58 $166,782 - $380,436	-4,200 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$27.07 - $84.35 $113,694 - $354,270	4,200 New	4,200 $294,000

247

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $163M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Arlington Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Financial Advisors, LLC with notifications on news.